Introduction: The response to vaccines in juvenile idiopathic arthritis (JIA) patients on and off anti-tumor necrosis factor (anti-TNF) agents remains highly discussed. There are no published studies on the immune response following a Tdap booster dose in JIA patients so far.
Objective: To evaluate the immune response and safety after a Tdap booster in JIA patients and in healthy adolescents.
© LitMetric 2025. All rights reserved.